Dr. Xiaosong Song, MD

Dr. Song practices at Viera Hospital in Melbourne, Florida, part of Health First.

Dr. Song's NPI, 1093941205, was assigned on June 2, 2009. Dr. Song graduated from China Medical University Shenyang in 1994. Dr. Song holds Florida license ME132088.

Dr. Song's primary practice is Viera Hospital, at 8745 N Wickham Rd, Melbourne, FL 32940 in Brevard County. The practice phone is (321) 434-9000.

Dr. Song's primary practice is Viera Hospital in Melbourne, Florida, part of Health First. Dr. Song is also affiliated with Holmes Regional Medical Center. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Song to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Song practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Song's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Song is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Song's licenses on file in 2 states: Florida and New York.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroenteritis among the conditions Dr. Song treats.

CMS data shows 917 Medicare services from Dr. Song across 15 procedure codes in 2024, for 521 Medicare patients. Medicare paid $88,545 for them.

CMS counts 521 Medicare patients who saw Dr. Song in 2024. The largest group is 65 to 74, with 260 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Song's median patient age at 67, with 58% women.

In 2024, Dr. Song wrote 788 Medicare Part D claims for 357 patients. 84% of them were for generic drugs. CMS names the drug for 636 of them, across 12 drugs with 11 or more claims each, at $37,717 in total drug cost. In 2023, CMS named 772 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Song for performance year 2024, reported through an alternative payment model (APM). Dr. Song accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Song as offering telehealth. CMS counts 317 procedures of colonoscopy by Dr. Song, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Song in 2011. Dr. Song's most frequent co-author is Lin Mei, MD.

CMS Open Payments shows 187 general payments to Dr. Song from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Allergan Inc. paid the most, $6,305.

Dr. Song graduated from China Medical University Shenyang in 1994. Dr. Song is a member of ACG and American Society of Gastrointestinal Endoscopy.

Dr. Song is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.